NCT04225949 is a NA clinical trial of survey 1 in Orthopedic Disorder, sponsored by Stanford University.

Who is sponsoring NCT04225949?

NCT04225949 is sponsored by Stanford University.

What drugs are being tested in NCT04225949?

Interventions in NCT04225949: survey 1, survey 2.

What condition does NCT04225949 study?

NCT04225949 studies Orthopedic Disorder.

Is NCT04225949 still recruiting?

NCT04225949 is currently withdrawn. Last updated 9 April 2025.

Last reviewed 2025-04-09 · How we verify

NCT04225949

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patients Understanding of PROM Graphs

Withdrawn NA Last updated 9 April 2025

What this trial tests

NA trial testing survey 1 in Orthopedic Disorder. Withdrawn.

Timeline

15 May 2040

Primary endpoint
1 August 2040

1 August 2040

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	health services research
Start date	15 May 2040
Primary completion	1 August 2040
Estimated completion	1 August 2040

Drugs / interventions tested

survey 1
survey 2

Conditions studied

Orthopedic Disorder — all drugs for Orthopedic Disorder →

Sponsor

Stanford University

Who can join

18 and older, any sex, with Orthopedic Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates patients' ability to understand PROM scores when presented in graphs. One half will receive one version of the survey, while the other half will receive a second version of the survey.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Orthopedic Disorder

Currently open trials in the same condition.

NCT06991205 — Web-based Mind-body Program to Improve Resilience Among Risky Substance Users With Persistent Upper Extremity Pain · NA · recruiting
NCT06002009 — SupraScapular Cuff Study: Assessing the Effects of Size and Type of Rotator Cuff Tear on Suprascapular Nerve Function · recruiting
NCT06869343 — Early Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture · NA · recruiting
NCT06877078 — Effect of Pre-Surgery Constipation Podcast: A RCT · NA · recruiting
NCT06579599 — Study on the Preventive Effect of Establishing an Integrated Working Group of Doctors and Nurses in Operating Room · NA · recruiting

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT07337655 — Efficacy and Safety of Aspirin and Lansoprazole for Prevention of Preterm Birth in High-Risk Pregnant Women: A Biomarker · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04225949 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 9 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04225949.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing